UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000060478 |
|---|---|
| Receipt number | R000068927 |
| Scientific Title | Effect of food-containing ingredients on human adipose tissue (SIC-2025-03-ENERGY) |
| Date of disclosure of the study information | 2026/01/27 |
| Last modified on | 2026/01/27 09:45:09 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Effect of food-containing ingredients on human adipose tissue
(SIC-2025-03-ENERGY)
Acronym
Effect of food-containing ingredients on human adipose tissue
Scientific Title
Effect of food-containing ingredients on human adipose tissue
(SIC-2025-03-ENERGY)
Scientific Title:Acronym
Effect of food-containing ingredients on human adipose tissue
Region
| Japan |
Condition
Condition
Not applicable
Classification by specialty
| Not applicable | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate the effect of food-containing ingredients on human adipose tissue.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
SUVmax
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
Ingredient-containing food (8 weeks)
Interventions/Control_2
Ingredient-free food (8 weeks)
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 65 | years-old | > |
Gender
Male and Female
Key inclusion criteria
(1) Healthy men and women who are 20 <= years old <65.
(2) Subject who can come to the facility on the designated day.
(3) Subjects who can make self-judgment and are voluntarily giving written informed consent.
Key exclusion criteria
(1) Subjects whose systolic pressure <90 mmHg.
(2) Subjects in pregnancy or lactation
(3) Subjects who are participating in other clinical studies, or who finished clinical study within 4 weeks.
(4) Subjects who are applicable to following items
a) Subjects with disease on heart, liver, kidney or other organs complication.
b) Subjects with a previous history of disease on circulatory organs.
c) Subjects who are contracting diabetes.
d) Subjects with a history of cancer, tuberculosis, or other serious illness
(5) Subjects who have an unsteady lifestyle because of a working shift or a night shift.
(6) Smoker
(7) Subjects who drink a lot.
(8) Subjects whose BMI is less the 18.5 or over 25.0
(9) Subjects who are judged as unsuitable for the study by the principal investigator for other reasons.
Target sample size
24
Research contact person
Name of lead principal investigator
| 1st name | Toshihide |
| Middle name | |
| Last name | Suzuki |
Organization
Suntory Global Innovation Center Ltd.
Division name
Research Institute
Zip code
619-0284
Address
8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto, Japan
TEL
050-1804-0232
Toshihide_Suzuki@suntory.co.jp
Public contact
Name of contact person
| 1st name | Natsumi |
| Middle name | |
| Last name | Hiraki |
Organization
Suntory Global Innovation Center Ltd.
Division name
Research Institute
Zip code
619-0284
Address
8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto, Japan
TEL
050-1804-0208
Homepage URL
Natsumi_Hiraki@suntory.co.jp
Sponsor or person
Institute
Suntory Global Innovation Center Ltd.
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Medical Corporation Jikokai Fukuzumi Internal Medicine Clinic Clinical Trial Review Committee
Address
1-2-5 Fukuzumi-2 jo, Toyohira-ku, Sapporo-shi, Hokkaido.
Tel
011-836-3531
shibata@jkkai.or.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 01 | Month | 27 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2025 | Year | 11 | Month | 17 | Day |
Date of IRB
Anticipated trial start date
| 2026 | Year | 01 | Month | 28 | Day |
Last follow-up date
| 2026 | Year | 04 | Month | 07 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2026 | Year | 01 | Month | 27 | Day |
Last modified on
| 2026 | Year | 01 | Month | 27 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068927
